1. Gilead says remdesivir cut risk of COVID patient death in clinical trial — BioNTech-Pfizer COVID vaccine expected to be ready for approval by year end — LEO Pharma eyeing 2021 launch for Dupixent rival — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

50% Reduction

Discussion in 'Otsuka' started by anonymous, Nov 30, 2016 at 7:46 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    AGREE!
     

  2. anonymous

    anonymous Guest

    KM didn't retire - it was LG.
     
  3. anonymous

    anonymous Guest

    Oh Grow Up! maybe we should create a "safe space" for all the losers we let go. This is business. Keep your resume out and network even when you have a solid job. This is the pharma industry boys and girlsk pull up your big boy pants and take it like men!!
     
  4. anonymous

    anonymous Guest

    You're right but the company is a total joke. There are way better companies out there who will not treat us like numbers. Most people laugh when you mention the name.
     
  5. anonymous

    anonymous Guest

    Yep, and was forced to retire! About time!
     
  6. anonymous

    anonymous Guest

     
  7. anonymous

    anonymous Guest

    wow